HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index. For more information regarding HCP, visit www.hcpi.com.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
SymbolNYSE:HCP
CUSIP40414L10
Phone949-407-0700
Debt
Debt-to-Equity Ratio1.37
Current Ratio0.51
Quick Ratio0.51
Price-To-Earnings
Trailing P/E Ratio13.87
Forward P/E Ratio14.80
P/E Growth6.75
Sales & Book Value
Annual Sales$1.85 billion
Price / Sales6.85
Cash Flow$2.0589 per share
Price / Cash13.08
Book Value$11.93 per share
Price / Book2.26
Profitability
EPS (Most Recent Fiscal Year)$1.95
Net Income$414.16 million
Net Margins3.39%
Return on Equity1.12%
Return on Assets0.45%
Miscellaneous
Employees190
Outstanding Shares469,830,000
Market Cap$12.79 billion
HCP (NYSE:HCP) Frequently Asked Questions
What is HCP's stock symbol?
HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."
How often does HCP pay dividends? What is the dividend yield for HCP?
HCP announced a quarterly dividend on Thursday, July 26th. Stockholders of record on Wednesday, August 8th will be paid a dividend of $0.37 per share on Tuesday, August 21st. This represents a $1.48 annualized dividend and a dividend yield of 5.50%. The ex-dividend date of this dividend is Friday, August 3rd. View HCP's Dividend History.
How were HCP's earnings last quarter?
HCP, Inc. (NYSE:HCP) announced its quarterly earnings results on Thursday, August, 2nd. The real estate investment trust reported $0.19 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.46 by $0.27. The real estate investment trust earned $469.60 million during the quarter, compared to analyst estimates of $463.94 million. HCP had a return on equity of 1.12% and a net margin of 3.39%. The firm's revenue was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.48 EPS. View HCP's Earnings History.
When is HCP's next earnings date?
What guidance has HCP issued on next quarter's earnings?
HCP updated its FY18 earnings guidance on Thursday, August, 2nd. The company provided EPS guidance of $1.65-1.69 for the period, compared to the Thomson Reuters consensus estimate of $1.81.
What price target have analysts set for HCP?
16 brokerages have issued 12-month price objectives for HCP's stock. Their predictions range from $21.00 to $29.00. On average, they anticipate HCP's stock price to reach $26.25 in the next year. This suggests that the stock has a possible downside of 2.5%. View Analyst Price Targets for HCP.
What is the consensus analysts' recommendation for HCP?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 2 sell ratings, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for HCP.
What are Wall Street analysts saying about HCP stock?
Here are some recent quotes from research analysts about HCP stock:
- 1. Cantor Fitzgerald analysts commented, "We are initiating coverage of HCP with a $28 price target and a Neutral rating. HCP has risen by 16% over the past three months, along with other large-cap REITs, but it is down 17.5% over the past year, compared with a 14% gain in the 12% decline in the S&P U.S. Healthcare REIT Index. We believe that most of the stock’s relative weakness reflects concern about interest rates, deteriorating fundamentals in senior housing and HCP’s restructuring. With HCP’s restructuring nearly at an end, we expect investors to begin valuing the company more on its fundamentals, which we expect to improve, and to worry less about interest rates. Although we think senior housing could remain slow for awhile, we are enthusiastic about HCP’s strategy to leverage its position in life science and MOB." (8/7/2018)
- 2. According to Zacks Investment Research, "HCP’s second-quarter 2018 funds from operations (FFO) as adjusted of 47 cents per share surpassed the Zacks Consensus Estimate by a whisker. Further, the company reported higher revenues and net operating income (NOI) on a year-over-year basis. Encouragingly, it increased the guidance for 2018 FFO per share. The company has undertaken strategic portfolio-repositioning measures in a bid to improve the quality of the senior housing portfolio and lower the Brookdale Senior Living operator concentration by selling assets in its portfolio. Further, shares of HCP have outperformed the industry it belongs to over the past three months. Although efforts to reduce the Brookdale concentration are a strategic fit for the long term, the dilutive impact on earnings in the near term from the sale of assets is unavoidable. Further, soft seniors housing market fundamentals amid new supply is anticipated to thwart the company’s pricing power." (8/7/2018)
Who are some of HCP's key competitors?
Some companies that are related to HCP include CROWN CASTLE In/SH SH (CCI), Public Storage (PSA), Prologis (PLD), Equinix (EQIX), Weyerhaeuser (WY), DIGITAL RLTY TR/SH (DLR), AvalonBay Communities (AVB), Equity Residential (EQR), Welltower (WELL), UNIBAIL-RODAMCO/ADR (UNRDY), Ventas (VTR), GGP (GGP), Boston Properties (BXP), SBA Communications (SBAC) and Realty Income (O).
Who are HCP's key executives?
HCP's management team includes the folowing people:
- Mr. Thomas M. Herzog, Pres, CEO & Director (Age 55)
- Mr. Peter A. Scott, Exec. VP & CFO (Age 38)
- Mr. Thomas M. Klaritch, Exec. VP & COO (Age 60)
- Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 45)
- Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 41)
Has HCP been receiving favorable news coverage?
News stories about HCP stock have been trending somewhat positive recently, according to Accern Sentiment. The research firm rates the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. HCP earned a coverage optimism score of 0.12 on Accern's scale. They also gave headlines about the real estate investment trust an impact score of 46.04 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for HCP.
Who are HCP's major shareholders?
HCP's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.47%), Security Capital Research & Management Inc. (2.70%), Dimensional Fund Advisors LP (1.53%), Resolution Capital Ltd (1.38%), Centersquare Investment Management LLC (1.35%) and Bank of New York Mellon Corp (1.28%). Company insiders that own HCP stock include Darren A Kowalske, Jonathan M Bergschneider, Kendall K Young, R Kent Griffin Jr, Scott A Anderson, Thomas D Kirby and Thomas Klaritch. View Institutional Ownership Trends for HCP.
Which institutional investors are selling HCP stock?
HCP stock was sold by a variety of institutional investors in the last quarter, including Centersquare Investment Management LLC, Russell Investments Group Ltd., Morgan Stanley, Canada Pension Plan Investment Board, BlackRock Inc., Millennium Management LLC, SG Americas Securities LLC and Bank of New York Mellon Corp. View Insider Buying and Selling for HCP.
Which institutional investors are buying HCP stock?
HCP stock was bought by a variety of institutional investors in the last quarter, including Resolution Capital Ltd, AEW Capital Management L P, Security Capital Research & Management Inc., American Century Companies Inc., Securian Asset Management Inc, Janus Henderson Group PLC, Sei Investments Co. and Bank of America Corp DE. Company insiders that have bought HCP stock in the last two years include Kendall K Young and R Kent Griffin Jr. View Insider Buying and Selling for HCP.
How do I buy shares of HCP?
Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HCP's stock price today?
One share of HCP stock can currently be purchased for approximately $26.93.
How big of a company is HCP?
HCP has a market capitalization of $12.79 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $414.16 million in net income (profit) each year or $1.95 on an earnings per share basis. HCP employs 190 workers across the globe.
How can I contact HCP?
HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected]
MarketBeat Community Rating for HCP (NYSE HCP)
MarketBeat's community ratings are surveys of what our community members think about HCP and other stocks. Vote "Outperform" if you believe HCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCP will underperform the S&P 500 over the long term. You may vote once every thirty days.
